(*) USA Approval Date: 2019. 04.12.
>Has Susceptible FGFR2 or FGFR3>
>Have Progressed During or After>
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2019. 12.24.
PR Web-Site
TradeMark
TradeMark Web-Site